Sign up to save your podcasts
Or
Share Vorasidenib and grading of IDH mutant astrocytoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vorasidenib and grading of IDH mutant astrocytoma
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
More shows like Neuro-Oncology: The Podcast
View all
Global News Podcast
7,686 Listeners
Science Weekly
413 Listeners
Freakonomics Radio
32,030 Listeners
The Daily
110,916 Listeners
Up First from NPR
55,879 Listeners
OncLive® On Air
21 Listeners
Lung Cancer Considered
26 Listeners
Neurosurgery Podcast
111 Listeners
The Rest Is History
12,503 Listeners
The Ezra Klein Show
15,316 Listeners
The Weekly Show with Jon Stewart
10,240 Listeners
Pop Culture Parenting
68 Listeners
Glioblastoma aka GBM
25 Listeners
Oncology for the Inquisitive Mind
4 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
38 Listeners